within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01X_OtherAntibacterials.J01XD01_Metronidazole;

model Metronidazole_1
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 1.0833333333333333e-06,
    adminDuration = 600,
    adminMass = 500 / 1000000,
    adminCount = 1,
    Vd = 0.039,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.0162,
    k12 = 1.25e-06,
    k21 = 1.25e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Metronidazole_1</td></tr><tr><td>ATC code:</td><td>J01XD01_1</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>500</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>39.0</td><td>L</td></tr>
    <tr><td>clearance:</td><td>65</td><td>mL/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Metronidazole is a nitroimidazole antimicrobial agent used primarily to treat infections caused by anaerobic bacteria and certain parasites. It is approved for use in bacterial vaginosis, trichomoniasis, giardiasis, amebiasis, and various anaerobic infections. Metronidazole is widely used in clinical practice, both in hospital and outpatient settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters following single intravenous infusion in healthy adults.</p><h4>References</h4><ol><li><p>Suyagh, M, et al., &amp; McElnay, JC (2011). Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling. <i>Pediatrics</i> 127(2) e367–e374. DOI:<a href=\"https://doi.org/10.1542/peds.2010-0807\">10.1542/peds.2010-0807</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21220396/\">https://pubmed.ncbi.nlm.nih.gov/21220396</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=\"https://doi.org/10.1007/s40272-013-0017-5\">10.1007/s40272-013-0017-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23529866/\">https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li><li><p>Arnold, DT, et al., &amp; MacGowan, A (2024). Antibiotic pharmacokinetics in infected pleural effusions. <i>Thorax</i> 79(9) 883–885. DOI:<a href=\"https://doi.org/10.1136/thorax-2023-220402\">10.1136/thorax-2023-220402</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38964858/\">https://pubmed.ncbi.nlm.nih.gov/38964858</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.J.J01XD01_1 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Metronidazole_1;
